Latest California Healthline Stories
Old Drug Turned ‘Cash Cow’ as Company Pumped Price to $40K a Vial, Emails Show
The CEO of Mallinckrodt Pharmaceuticals defended the price hikes of Acthar gel, an orphan drug that treats infantile spasms at a House Oversight Committee hearing on Thursday.
Sky-High Drug Prices Driven by Pharma Profits, House Dems Charge
Democrats on the House Oversight Committee released a damning investigation Wednesday of drug company pricing tactics and profits, as two days of hearings with testimony from pharmaceutical industry CEOs begin.
Corralling the Facts on Herd Immunity
The term “herd immunity” has found its way into politicized discussions about how to overcome the COVID-19 pandemic. But what does it actually mean? And does it work?
Trump’s Executive Order on Preexisting Conditions Lacks Teeth, Experts Say
President Donald Trump’s executive order says that people with preexisting conditions can get affordable insurance. But it doesn’t explain how.
Promises Kept? On Health Care, Trump’s Claims of ‘Monumental Steps’ Don’t Add Up
The president entered office seeking to overturn the Affordable Care Act, revamp Medicaid and drive down prescription drug prices, among other things. He’s hit some stone walls.
Cory Gardner’s Bill Has as Much to Do With Politics as Preexisting Conditions
The legislation falls short of the big challenge.
KHN’s ‘What the Health?’: The Politics of Science
Republicans have all but abandoned the Affordable Care Act as a campaign cudgel, judging from their national convention, at least. Meanwhile, career scientists at the federal government’s preeminent health agencies — the Food and Drug Administration, the Centers for Disease Control and Prevention and the National Institutes of Health — are all coming under increasing political pressure as the pandemic drags on. Joanne Kenen of Politico, Mary Ellen McIntire of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss this and more. Plus, Rovner interviews KHN’s Elizabeth Lawrence about the latest KHN-NPR “Bill of the Month” installment.
KHN’s ‘What the Health?’ Replay: What’s at Stake When High Court Hears ACA Case
The Supreme Court recently announced its schedule for hearing arguments in a case brought by Republican state officials seeking to overturn the Affordable Care Act. The “What the Health?” podcast is on vacation, but it seemed like a good opportunity to replay an episode from March looking at the federal health law on its 10th anniversary.
Politics Slows Flow of US Pandemic Relief Funds to Public Health Agencies
Congress has allocated trillions of dollars to ease the coronavirus crisis. A joint KHN and AP investigation finds that many communities with big outbreaks have spent little of that federal money on local public health departments for work such as testing and contact tracing. Others, like Minnesota, were slow to do so. Bureaucracy has bogged things down, politics have crept into the process, and understaffed departments have struggled to take time away from critical needs to navigate the red tape required to justify asking for more money.
La política frena el flujo de fondos a las agencias para frenar la pandemia
Desde que comenzó la pandemia, el Congreso ha reservado miles de millones para aliviar la crisis. Pero parte de ese dinero no se ha distribuido, o gastado, apropiadamente.